Frankfurt - Delayed Quote EUR

Context Therapeutics Inc. (6K9.F)

Compare
0.7300
+0.0150
+(2.10%)
At close: 8:20:58 AM GMT+1

Research Analysis

Revenue vs. Earnings

Revenue --
Earnings -17.46M

Q4'23

Q1'24

Q2'24

Q3'24

-15M
-10M
-5M
0
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 5366
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) 0.00%0.00%0.00%0.00%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
6K9.F --------
S&P 500 13.90%7.87%13.12%14.10%

Upgrades & Downgrades

Maintains D. Boral Capital: Buy to Buy 1/15/2025
Initiated JMP Securities: Market Outperform 1/8/2025
Initiated D. Boral Capital: Buy 11/25/2024
Reiterates HC Wainwright & Co.: Buy to Buy 9/23/2024
Reiterates HC Wainwright & Co.: Buy to Buy 9/16/2024
Reiterates HC Wainwright & Co.: Buy to Buy 7/10/2024

Related Tickers